Matches in SemOpenAlex for { <https://semopenalex.org/work/W2068200087> ?p ?o ?g. }
Showing items 1 to 92 of
92
with 100 items per page.
- W2068200087 endingPage "238" @default.
- W2068200087 startingPage "231" @default.
- W2068200087 abstract "Autoimmune vasculitides cannot always be controlled by steroids and immunosuppressive drugs. Intravenous immunoglobulin (IVIg) treatment was found beneficial in several vasculitides including systemic and organ-specific diseases. In this article we tested whether the beneficial clinical response of IVIg treatment in vasculitides was accompanied by a decrease in vasculitis-associated autoantibody levels.Ten patients diagnosed as having vasculitis were treated with high-dose (2 g/kg) IVIg monthly, in a 5-day schedule. In all the patients, other therapeutic measures failed to control disease progression prior to IVIg treatment. Each patient received between 1 and 6 treatment courses. All patients were evaluated for the levels of 5 autoantibodies (Abs) related to vasculitis before and after each treatment course.In 6 out of the 10 patients, a beneficial clinical response followed IVIg treatment. Moreover, no treatment-related adverse effects were observed in any of the patients. Anti-myeloperoxidase antibodies and cytoplasmic-antineutrophil cytoplasmic antibodies levels decreased concomitantly with the clinical improvement observed in the patients with Churg-Strauss vasculitis and Wegener's granulomatosis, respectively. Levels of cytoplasmic-antineutrophil cytoplasmic antibodies (ANCA) with specificity for bacteridial/permeability-increasing protein and human lysosomal-associated membrane protein increased after each treatment course, but returned to normal values before the following one.When other therapeutic measures, such as immunosuppressive therapy, fails to control disease manifestations in patients with vasculitides, IVIg is a possible effective intervention method with a high response rate. IVIg probably exerted its effects on disease progression via different mechanisms. Among these mechanisms, a decrease in relevant Ab levels is often found (probably by anti-idiotypes in IVIg), and thus ANCA levels are expected to associate with disease activity." @default.
- W2068200087 created "2016-06-24" @default.
- W2068200087 creator A5018204207 @default.
- W2068200087 creator A5018365193 @default.
- W2068200087 creator A5025700190 @default.
- W2068200087 creator A5028623436 @default.
- W2068200087 creator A5029211662 @default.
- W2068200087 creator A5030650333 @default.
- W2068200087 creator A5074738902 @default.
- W2068200087 creator A5075106701 @default.
- W2068200087 creator A5083488408 @default.
- W2068200087 creator A5088584321 @default.
- W2068200087 date "1999-01-01" @default.
- W2068200087 modified "2023-10-03" @default.
- W2068200087 title "Serologic and Clinical Response to Treatment of Systemic Vasculitis and Associated Autoimmune Disease with Intravenous Immunoglobulin" @default.
- W2068200087 cites W2033047305 @default.
- W2068200087 cites W2069080858 @default.
- W2068200087 doi "https://doi.org/10.1159/000024199" @default.
- W2068200087 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10436395" @default.
- W2068200087 hasPublicationYear "1999" @default.
- W2068200087 type Work @default.
- W2068200087 sameAs 2068200087 @default.
- W2068200087 citedByCount "81" @default.
- W2068200087 countsByYear W20682000872012 @default.
- W2068200087 countsByYear W20682000872013 @default.
- W2068200087 countsByYear W20682000872014 @default.
- W2068200087 countsByYear W20682000872015 @default.
- W2068200087 countsByYear W20682000872017 @default.
- W2068200087 countsByYear W20682000872018 @default.
- W2068200087 countsByYear W20682000872019 @default.
- W2068200087 countsByYear W20682000872022 @default.
- W2068200087 crossrefType "journal-article" @default.
- W2068200087 hasAuthorship W2068200087A5018204207 @default.
- W2068200087 hasAuthorship W2068200087A5018365193 @default.
- W2068200087 hasAuthorship W2068200087A5025700190 @default.
- W2068200087 hasAuthorship W2068200087A5028623436 @default.
- W2068200087 hasAuthorship W2068200087A5029211662 @default.
- W2068200087 hasAuthorship W2068200087A5030650333 @default.
- W2068200087 hasAuthorship W2068200087A5074738902 @default.
- W2068200087 hasAuthorship W2068200087A5075106701 @default.
- W2068200087 hasAuthorship W2068200087A5083488408 @default.
- W2068200087 hasAuthorship W2068200087A5088584321 @default.
- W2068200087 hasConcept C126322002 @default.
- W2068200087 hasConcept C159654299 @default.
- W2068200087 hasConcept C163764329 @default.
- W2068200087 hasConcept C197934379 @default.
- W2068200087 hasConcept C203014093 @default.
- W2068200087 hasConcept C24040308 @default.
- W2068200087 hasConcept C2776015282 @default.
- W2068200087 hasConcept C2777374719 @default.
- W2068200087 hasConcept C2778910314 @default.
- W2068200087 hasConcept C2779075594 @default.
- W2068200087 hasConcept C2779134260 @default.
- W2068200087 hasConcept C45189115 @default.
- W2068200087 hasConcept C71924100 @default.
- W2068200087 hasConcept C90924648 @default.
- W2068200087 hasConceptScore W2068200087C126322002 @default.
- W2068200087 hasConceptScore W2068200087C159654299 @default.
- W2068200087 hasConceptScore W2068200087C163764329 @default.
- W2068200087 hasConceptScore W2068200087C197934379 @default.
- W2068200087 hasConceptScore W2068200087C203014093 @default.
- W2068200087 hasConceptScore W2068200087C24040308 @default.
- W2068200087 hasConceptScore W2068200087C2776015282 @default.
- W2068200087 hasConceptScore W2068200087C2777374719 @default.
- W2068200087 hasConceptScore W2068200087C2778910314 @default.
- W2068200087 hasConceptScore W2068200087C2779075594 @default.
- W2068200087 hasConceptScore W2068200087C2779134260 @default.
- W2068200087 hasConceptScore W2068200087C45189115 @default.
- W2068200087 hasConceptScore W2068200087C71924100 @default.
- W2068200087 hasConceptScore W2068200087C90924648 @default.
- W2068200087 hasIssue "3" @default.
- W2068200087 hasLocation W20682000871 @default.
- W2068200087 hasLocation W20682000872 @default.
- W2068200087 hasOpenAccess W2068200087 @default.
- W2068200087 hasPrimaryLocation W20682000871 @default.
- W2068200087 hasRelatedWork W1556689649 @default.
- W2068200087 hasRelatedWork W156947643 @default.
- W2068200087 hasRelatedWork W1987061714 @default.
- W2068200087 hasRelatedWork W1999635097 @default.
- W2068200087 hasRelatedWork W2006436522 @default.
- W2068200087 hasRelatedWork W2112007484 @default.
- W2068200087 hasRelatedWork W2341047070 @default.
- W2068200087 hasRelatedWork W2789420638 @default.
- W2068200087 hasRelatedWork W2942917434 @default.
- W2068200087 hasRelatedWork W40526389 @default.
- W2068200087 hasVolume "119" @default.
- W2068200087 isParatext "false" @default.
- W2068200087 isRetracted "false" @default.
- W2068200087 magId "2068200087" @default.
- W2068200087 workType "article" @default.